Allergan And Cenicriviroc In NASH: The Forgotten

Market Assessment Allergan (AGN) is a commercial-stage large market cap ($45.9B) biopharma developing innovative and generic therapeutics for diseases affecting the eyes, bowel, lungs, skin, urogenital systems and brain. Through the acquisition of Tobira Therapeutics, Allergan has been clinically developing cenicriviroc (CVC) as a potential therapy for the chronic liver disease, NASH. Allergan is also…

Trump wants to quiz immigrants on civics — but many natural born Americans lack basic knowledge of government

President Donald Trump wants legal immigrants to pass a civics exam before they’re allowed to enter the country — but many natural-born Americans may struggle with such a test. Trump proposed the new civics-test requirement Thursday as part of a sweeping overhaul to America’s legal immigration system, which he wants to turn into a merit-based…